Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Melatonin for Impacted Third Molar Extraction
NCT04424875Phase 3Completed
- Sponsor
- Fayoum University
- Start
- Jul 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Mucomel in Impacted Mandibular Third Molar (IM3M), sponsored by Fayoum University. Started Jul 2020; status: completed.
02
Drugs
Mucomel
03
Conditions
Impacted Mandibular Third Molar (IM3M)
Beyond the preview
Go deeper on NCT04424875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04424875.